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Background
It has been postulated that NPH equals pressure- and dis-
tortion-induced ischemia. Such a postulate fails to take
into consideration the high co-incidence of AD and cere-
brovascular disease (CVD) with NPH; as well as the obser-
vation that ischemia persists despite resolution of the
elevated CSFP and ventriculomegaly [1,2]. We offer an
alternate postulate, that NPH is a multi-factorial disease
and that defective metabolite clearance, e.g., amyloid-beta
peptides (Aβ) and Tau protein, via the CSF and across the
blood-brain barrier (BBB), play a significant role in the
dementia and ischemia of NPH.
Materials and methods
Aged Sprague-Dawley rats (12 mos) had hydrocephalus
induced by intracisternal kaolin injection [3]. Brains were
harvested at two, six and 10 weeks post-induction, n = 4–
6 for each experimental group. The brains were stained for
Aβ, hyperphosphorylated Tau (hpTau), and the Aβ trans-
porters LRP-1, Pgp and RAGE (receptor for advanced gly-
cation end products) by immunohistochemistry (IHC).
Three epitopes of hpTau were used: pT231, pS262
(intraneuronal) and AT100 (extraneuronal). Cerebral
microvessel isolations (MVIs) were performed and the
extracted RNA and protein were assayed for the Aβ trans-
port proteins. Western blots and ELISA were used to assay
Aβ and Tau accumulation. Aged matched non-operated
rats serves as controls.
Results
On IHC, Aβ accumulated in cortex and hippocampus with
increasing hydrocephalus, particularly around microves-
sels and in and around neurons. HpTau, pT231, was seen
in neurons in a typical AD pattern: loss of dendritic hpTau
and accumulation and margination of hpTau granules in
the cell soma. Extracellular hpTau, AT100, was also seen
to accumulate around blood vessels. The Aβ transport
proteins were significantly altered in the MVIs compared
to controls: LRP-1 and Pgp were down-regulated whereas
RAGE was up-regulated.
Conclusion
These studies show that induction of hydrocephalus
(increased resistance to CSF absorption and decreased
CSF production and turnover) leads to defective CSF and
BBB metabolite clearance, and to the accumulation of Aβ
and hpTau, similar to what is seen in AD [4,5]. The local-
ization of Aβ, a known vasoconstrictor, and hpTau to cer-
ebral blood vessels suggests that these toxins may play a
role in the persistent ischemia and CVD seen in NPH.
Hydrocephalus in aged animals, therefore, causes severe
metabolic dysfunction, due to a progressive inability to
clear metabolites, and is likely a major cause of the
pathology in NPH.
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